A Phase 2, Single-Blind, Exploratory, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Daily Oral NYX-2925 in Subjects With Fibromyalgia
Phase: PHASE2
Conditions: Fibromyalgia
Sponsor: Aptinyx

NCT03249103 
NYX-2925-2002 
A Phase 2, Single-Blind, Exploratory, Placebo-controlled, Pilot Study to Assess the 
Efficacy and Safety of Daily Oral NYX-2925 in Subjects With Fibromyalgia  
Protocol 
March 7, 2018